Ask AI
ProCE Banner Activity

New Evidence and Novel Therapeutic Strategies in Myelofibrosis Care: Key Presentations at ASH 2023

PDF

Download this list of key presentations at ASH 2023 related to evidence-based strategies in the care of patients with myelofibrosis.

Released: November 29, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from CTI BioPharma Corp, Geron Corporation, GlaxoSmithKline LLC, and Karyopharm Therapeutics Inc.

CTI BioPharma Corp., a Sobi Company

Geron Corporation

GlaxoSmithKline LLC

Karyopharm Therapeutics Inc.

Disclosure

Primary Author

Jean-Jacques Kiladjian, MD, PhD

Professor of Medicine, Consultant Hematologist
Saint-Louis Hospital, Paris Cite University
Paris, France

Jean-Jacques Kiladjian, MD, PhD: consultant/advisor/speaker: AbbVie, AOP, Bristol Myers Squibb, GSK, Novartis.

Abdulraheem Yacoub, MD

Professor of Medicine
Clinical Director of Ambulatory Hematology Clinics
The Division of Hematologic Malignancies and Cellular Therapeutics (HMCT)
Department of Internal Medicine
The University of Kansas Cancer Center
Kansas City, Kansas

Abdulraheem Yacoub, MD, has no relevant relationships to disclose.